BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7791110)

  • 1. Effects of a K+ channel blocker on glomerular filtration rate and electrolyte excretion in conscious rats.
    Ludens JH; Clark MA; Lawson JA
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1375-81. PubMed ID: 7791110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natriuretic activity of the K+ channel blocker U-37883A displays an ADH-dependence.
    Clark MA; Lawson JA; Ludens JH
    Methods Find Exp Clin Pharmacol; 1998 Mar; 20(2):115-23. PubMed ID: 9604853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a novel KATP channel blocker on renal tubule function and K channel activity.
    Wang T; Wang WH; Klein-Robbenhaar G; Giebisch G
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1382-9. PubMed ID: 7791111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of KATP channel blocker U37883A on renal function in experimental diabetes mellitus in rats.
    Vallon V; Albinus M; Blach D
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1215-21. PubMed ID: 9732381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique natriuretic properties of the ATP-sensitive K(+)-channel blocker glyburide in conscious rats.
    Clark MA; Humphrey SJ; Smith MP; Ludens JH
    J Pharmacol Exp Ther; 1993 May; 265(2):933-7. PubMed ID: 8496833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of the K-ATP channel blocker U-37883A and structurally related morpholinoguanidines.
    Humphrey SJ; Smith MP; Cimini MG; Buchanan LV; Gibson JK; Khan SA; Meisheri KD
    Methods Find Exp Clin Pharmacol; 1996 May; 18(4):247-60. PubMed ID: 8803957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of the potassium channel opener minoxidil on renal electrolytes transport in the loop of henle.
    Wang T
    J Pharmacol Exp Ther; 2003 Feb; 304(2):833-40. PubMed ID: 12538840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Profile of U-37883A, a Channel Blocker of Smooth Muscle-Type ATP-Sensitive K Channels.
    Teramoto N
    Cardiovasc Drug Rev; 2006; 24(1):25-32. PubMed ID: 16939631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eukaliuric diuresis and natriuresis in response to the KATP channel blocker U37883A: micropuncture studies on the tubular site of action.
    Huang DY; Osswald H; Vallon V
    Br J Pharmacol; 1999 Aug; 127(8):1811-8. PubMed ID: 10482911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of K-ATP blocking guanidine diuretics during experimental kaliuresis in rats and dogs.
    Humphrey SJ
    Methods Find Exp Clin Pharmacol; 1995 Oct; 17(8):519-28. PubMed ID: 8749224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple actions of U-37883A, an ATP-sensitive K+ channel blocker, on membrane currents in pig urethra.
    Tomoda T; Yunoki T; Naito S; Ito Y; Teramoto N
    Eur J Pharmacol; 2005 Nov; 524(1-3):1-10. PubMed ID: 16242124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor binding characterization in kidney membrane of [3H]U-37883, a novel ATP-sensitive K+ channel blocker with diuretic/natriuretic properties.
    Meisheri K; Fosset M; Humphrey S; Lazdunski M
    Mol Pharmacol; 1995 Jan; 47(1):155-63. PubMed ID: 7838124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diuretic activity of N'-disubstituted morpholinoguanidine analogs of U-37883A in rats and dogs.
    Humphrey SJ; Ludens JH; Perricone SC; Skaletzky LL; Graham BE; Zins GR
    Methods Find Exp Clin Pharmacol; 1995 May; 17(4):255-66. PubMed ID: 7475512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanidine derivative U-37883A, inhibits mitochondrial K+ uniport.
    Szewczyk A; Wójcik G; Jabłonowska A; Nałecz
    Pol J Pharmacol; 1995; 47(4):339-44. PubMed ID: 8616514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells.
    Guillemare E; Honore E; De Weille J; Fosset M; Lazdunski M; Meisheri K
    Mol Pharmacol; 1994 Jul; 46(1):139-45. PubMed ID: 8058048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium orthovanadate diuresis in rats.
    Roman RJ; Bonventre JV; Silva P; Lechene C
    J Pharmacol Exp Ther; 1981 Jul; 218(1):168-74. PubMed ID: 6264066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zea mays L. extracts modify glomerular function and potassium urinary excretion in conscious rats.
    Velazquez DV; Xavier HS; Batista JE; de Castro-Chaves C
    Phytomedicine; 2005 May; 12(5):363-9. PubMed ID: 15957371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A micropuncture study on the renal site of action of ICI 206,970, a unique eukalemic diuretic.
    Johnston PA; Kau ST
    J Pharmacol Exp Ther; 1993 Feb; 264(2):604-8. PubMed ID: 8437111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the diuretics torasemide and U-37883A with the K(ATP) channel in rat isolated aorta.
    Löffler-Walz C; Quast U
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):230-7. PubMed ID: 9750009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium diet as a determinant for the renal response to systemic potassium channel modulation in anesthetized rats.
    Vallon V; Kirschenmann D; Brenner I; Albinus M; Osswald H
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):245-52. PubMed ID: 9750011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.